During murine infection studies, a bbk32 mutant exhibits attenuated infectivity at lower infection doses [47,52]; however, it is not clear if this phenotype is associated with the loss of BBK32 binding to ECM (GAGs or Fn) or due to abrogated BBK32-associated complement inhibitory activity. This evidence concerns the gene FN1 and infection.